-- New Phase 3 trial of Genasense(R) seeks to confirm benefit in melanoma BERKELEY HEIGHTS, N.J., Aug. 7 /PRNewswire-FirstCall/ -- Genta Incorporated (NASDAQ:GNTAD) today announced financial...
BERKELEY HEIGHTS, N.J., Aug. 2 /PRNewswire-FirstCall/ -- Genta Incorporated (NASDAQ:GNTAD) announced that the Company will release its second quarter 2007 financial results on Tuesday, August 7...
BERKELEY HEIGHTS, N.J., July 30 /PRNewswire-FirstCall/ -- Genta Incorporated (NASDAQ:GNTAD) announced today that the Company has been formally notified by NASDAQ that it has demonstrated...
AGENDA Trial Set to Confirm Findings in Marketing Application BERKELEY HEIGHTS, N.J., July 19 /PRNewswire-FirstCall/ -- Genta Incorporated (NASDAQ:GNTAD) announced today that it has received...
기간 | 변동 | 변동 % | 시가 | 고가 | 저가 | 평균 일일 거래량 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
도움 및 지원받기: kr-support@advfn.com
ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관